- Home
- KOSS vs CNTB Comparison
KOSS vs CNTB Comparison
Compare KOSS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- CNTB
- Stock Information
- Founded
- KOSS 1953
- CNTB 2012
- Country
- KOSS United States
- CNTB United States
- Employees
- KOSS N/A
- CNTB N/A
- Industry
- KOSS Consumer Electronics/Appliances
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- CNTB Health Care
- Exchange
- KOSS Nasdaq
- CNTB Nasdaq
- Market Cap
- KOSS 63.0M
- CNTB 68.5M
- IPO Year
- KOSS N/A
- CNTB 2021
- Fundamental
- Price
- KOSS $7.34
- CNTB $1.17
- Analyst Decision
- KOSS
- CNTB Strong Buy
- Analyst Count
- KOSS 0
- CNTB 1
- Target Price
- KOSS N/A
- CNTB $8.00
- AVG Volume (30 Days)
- KOSS 183.8K
- CNTB 24.6K
- Earning Date
- KOSS 11-08-2024
- CNTB 09-05-2024
- Dividend Yield
- KOSS N/A
- CNTB N/A
- EPS Growth
- KOSS N/A
- CNTB N/A
- EPS
- KOSS N/A
- CNTB N/A
- Revenue
- KOSS $12,265,069.00
- CNTB $24,116,000.00
- Revenue This Year
- KOSS N/A
- CNTB N/A
- Revenue Next Year
- KOSS N/A
- CNTB $63.90
- P/E Ratio
- KOSS N/A
- CNTB N/A
- Revenue Growth
- KOSS N/A
- CNTB N/A
- 52 Week Low
- KOSS $2.27
- CNTB $0.68
- 52 Week High
- KOSS $18.73
- CNTB $2.84
- Technical
- Relative Strength Index (RSI)
- KOSS 50.17
- CNTB 44.02
- Support Level
- KOSS $7.00
- CNTB $1.18
- Resistance Level
- KOSS $7.83
- CNTB $1.26
- Average True Range (ATR)
- KOSS 0.44
- CNTB 0.07
- MACD
- KOSS -0.01
- CNTB -0.01
- Stochastic Oscillator
- KOSS 32.26
- CNTB 13.59
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.